FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to pharmacology, and describes a liquid dosage form based on butylaminohydroxypropoxyphenoxymethyl methyloxadiazole. Dosage form based on butylaminohydroxypropoxyphenoxymethyl methyloxadiazole in form of an aqueous solution contains butylaminohydroxypropoxyphenoxymethyl methyloxadiazole in amount of 0.5 to 2 %, taurine from 0.5 to 4 % and methylethylpyridinol from 0.5 to 2 % in terms of total weight.
EFFECT: invention reduces side effects of antihypertensive preparations and can be used for treating primary open-angle glaucoma, as well as secondary glaucoma.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INFLUENCING AQUEOUS HUMOR DISCHARGE IN THE CASES OF PRIMARY OPEN ANGLE GLAUCOMA | 2003 |
|
RU2243749C1 |
| DISULFIRAM AND TAURINE-CONTAINING OPHTHALMOLOGICAL MEDICATION IN FORM OF EYE DROPS | 2012 |
|
RU2485939C1 |
| COMPOSITION FOR INTEGRATED TREATMENT OF PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AND OCULAR SURFACE DISEASES | 2011 |
|
RU2464985C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF GEL-LIKE OPHTHALMIC DROPS FOR TREATING GLAUCOMA | 2015 |
|
RU2576778C1 |
| COMPOSITION FOR INTEGRATED TREATMENT OF PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AND OCULAR SURFACE DISEASES | 2013 |
|
RU2517033C1 |
| ANTIGLAUCOMATOUS PREPARATION | 2000 |
|
RU2191013C2 |
| ANTIGLAUCOMATOUS AGENT | 1997 |
|
RU2128486C1 |
| COMBINED OPHTHALMIC AGENT | 2019 |
|
RU2733392C1 |
| METHOD FOR TREATING OPEN ANGLE GLAUCOMA | 1999 |
|
RU2173123C2 |
| METHOD OF TREATING PRIMARY GLAUCOMA IN PATIENTS WITH ACCOMPANYING ARTERIAL HYPERTENSION | 2015 |
|
RU2607291C1 |
